Aminolevulinic Acid
- Generic Name
- Aminolevulinic Acid
- Brand Names
- Ameluz, Gliolan, Levulan
- Drug Type
- Small Molecule
- Chemical Formula
- C5H9NO3
- CAS Number
- 106-60-5
- Unique Ingredient Identifier
- 88755TAZ87
- Background
A compound produced from succinyl-CoA and glycine as an intermediate in heme synthesis. It is used as a photochemotherapy for actinic keratosis. [PubChem]
- Indication
用于皮肤癌及鲍温病、牛皮癣，男性尿道尖锐湿疣等皮肤病。可治疗消化道肿瘤、口腔癌。可诊断和治疗膀胱癌、尿路上皮肿瘤。能阻止血管成形术后在狭窄。
- Associated Conditions
- Actinic Cheilitis, Actinic Keratoses of the face, Actinic Keratoses of the scalp, Actinic Keratosis (AK) of the Upper Extremity, Basal Cell Carcinoma (BCC), Cutaneous Squamous Cell Carcinoma in Situ (CSCCis), Glioma
- Associated Therapies
- -
Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis
Not Applicable
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 12
- Registration Number
- NCT00524485
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Photodynamic Therapy in Treating Patients With Skin Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-10-10
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 180
- Registration Number
- NCT00002975
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath